Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

11.8%

2 terminated/withdrawn out of 17 trials

Success Rate

71.4%

-15.1% vs industry average

Late-Stage Pipeline

24%

4 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

N/A
5(45.5%)
Phase 4
4(36.4%)
Phase 2
2(18.2%)
11Total
N/A(5)
Phase 4(4)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (17)

Showing 17 of 17 trials
NCT05911893Not ApplicableRecruiting

the Effect of High Caloric Oral Nutritional Supplements on Growth and Development of Malnourished Children

Role: collaborator

NCT07441746Not ApplicableNot Yet Recruiting

Clinical Implementation of the Group Standard for Enteral Feeding Care in Critically Ill Children

Role: collaborator

NCT04923828Recruiting

Chinese PICU Collaborative Network on Pathogens and Drug Resistance of Severe Infections

Role: collaborator

NCT07038538Not ApplicableRecruiting

Evidence-based Practice in the Management of Gastric Tube Placement in Children

Role: collaborator

NCT03850457Completed

Epidemiological Study for Bronchopulmonary Dysplasia (BPD) in China

Role: collaborator

NCT05759754Not ApplicableCompleted

Effects of Traditional Chinese Medicine (GSJYF) in Children With Inherited Proteinuric Kidney Disease

Role: collaborator

NCT06756022Recruiting

Dolasetron for the Prevention of CINV in Children With Acute Lymphoblastic Leukemia

Role: lead

NCT05152446Not ApplicableTerminated

Implementation of an Infusion Management Scheme to Improve Patient Outcome in Tertiary Children's Hospitals

Role: collaborator

NCT06607419Phase 2Recruiting

Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic Leukemia

Role: collaborator

NCT04783675Phase 2Completed

Efficacy and Safety of Rituximab in the First Episode of Pediatric Idiopathic Nephrotic Syndrome

Role: collaborator

NCT05092425Unknown

Analysis of Risk Factors for Children With Heterochronous Indirect Hernia

Role: collaborator

NCT04965467Withdrawn

Fabry Aim Children Early (ACE) Project

Role: collaborator

NCT04183725Phase 4Unknown

Clinical Study of Reduning Injection for the Treatment of Influenza in Children

Role: collaborator

NCT03266601Phase 4Completed

Effect of Recombinant Human Interferon α-2b Spray on Herpangina

Role: collaborator

NCT03249480Phase 4Unknown

Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency

Role: collaborator

NCT02094638Completed

Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study

Role: collaborator

NCT02296073Phase 4Unknown

The Efficacy and the Safety of Dexmedetomidine Sedation on the Pediatric Intensive Unit(PICU) Patients.

Role: lead

All 17 trials loaded